It is a nucleotide analogue developed by Bioenvision an™d manufactured by Genzyme. On December 29, 2004, it was approved by FDA for the treat♥ment of refractory or relapsed acute lymphoblastic leukemia (ALL) in children.
View detailsUpadacitinib(Scientific research)
Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that is market-orient↕ed and realizes industrial development through R&D innovatioσn and technology transformation.
View detailsBrigatinib(Scientific research)
Chenglian Pharmaceutical is an innovative high-tech pharmaceutica∏l enterprise that is market-oriented and realizes industrial de↓velopment through R&D innovation and technology transformation.
View detailsAbemaciclib(Scientific research)
Chenglian Pharmaceutical is an innovative high-tech pharmaceuticεal enterprise that is market-oriented and realizes industrial development through R&D in×novation and technology transformation.
View details
Follow WeChat
Anhui Union Pharmaceuticals Technology Co., Ltd.
Service line:
+86-21-54285906
E-mail:2880705932@qq.com
Add:4th Floor, Building B3, Creative Industry Park, Hefei, Anhui P. R. Chi na.
Copyright © 2022 Anhui Union Pharmaceuticals Technology Co., Ltd.